Advertisement
U.S. markets closed

Qiagen N.V. (QGEN)

NYSE - Nasdaq Real Time Price. Currency in USD
42.99+0.24 (+0.56%)
At close: 04:00PM EDT
42.99 0.00 (0.00%)
After hours: 04:07PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close42.75
Open42.54
Bid42.44 x 1000
Ask43.81 x 800
Day's Range42.43 - 43.05
52 Week Range34.74 - 47.70
Volume1,065,393
Avg. Volume1,262,952
Market Cap9.516B
Beta (5Y Monthly)0.41
PE Ratio (TTM)28.10
EPS (TTM)1.53
Earnings DateMay 01, 2024 - May 06, 2024
Forward Dividend & Yield1.28 (2.94%)
Ex-Dividend DateJan 30, 2024
1y Target Est51.05
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
7% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for QGEN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Qiagen N.V.
    Analyst Report: Qiagen N.V.Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).
    Rating
    Fair Value
    Economic Moat
    2 months agoMorningstar
View more